EMG
GNCA

Ellington Management Group’s Genocea Biosciences, Inc. GNCA Stock Holding History

Ellington Management Group’s Portfolio GNCA Stock Details GNCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,880
Closed -$200K – 919
2016
Q3 		$200K Buy
+4,880
New +$191K 0.06% 547

Other funds holding GNCA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
NC
Northpointe Capital Bloomfield Hills, Michigan $258M AUM 1.97% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
AA
AlphaMark Advisors Ft. Wright, Kentucky $231M AUM 19.98% 1-Year Est. Return

Ellington Management Group's GNCA Position: Q4 2016 in Review

Ellington Management Group sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2016, closing a stake of 4,880 shares — an estimated $200K sold.

Ellington Management Group first reported a position in GNCA in Q3 2016 and held it in 1 quarter. The position peaked at $200K in Q3 2016. 47 funds tracked by Wall St. Rank hold GNCA as of Q4 2016.

  • Ellington Management Group reported no remaining Genocea Biosciences, Inc. position as of Q4 2016 after selling out during the quarter.
  • Ellington Management Group sold 4,880 Genocea Biosciences, Inc. shares in Q4 2016, an estimated $200K.
  • Ellington Management Group first reported a position in Genocea Biosciences, Inc. in Q3 2016 and held it in 1 quarter.
  • Ellington Management Group's Genocea Biosciences, Inc. position peaked at $200K in Q3 2016.
  • 47 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2016.

Based on Ellington Management Group's 13F filing for Q4 2016, filed 14 Feb 2017.